Skip to main content
Premium Trial:

Request an Annual Quote

Zygogen, NuTec Partner to Develop Zebrafish Database

NEW YORK, June 15 - Zygogen has partnered with NuTec Sciences to help build its database of zebrafish genome data, the company said Friday. 

The database, called Z-base, is currently in preliminary form, said Nina Sawczuk, CEO of Zygogen, and NuTec will help design the database, add new sequence information, and "structure it in a more friendly way."

In addition, NuTec will write algorithms for performing comparative genomics studies with the human genome. Sawczuk added that the Sanger Centre is still sequencing the zebrafish genome, and that Zygogen would add the sequence data as it becomes available.

Zygogen, of Atlanta, Ga., plans to use the database to identify genes in humans associated with diseases such as angiogenesis, neurodegenerative, and cardiovascular disease.

The company is building its database with sequence data and information from zebrafish gene expression studies that use fluorescent tags to show the effect of gene mutations and drugs. Zygogen hopes that when this information is combined into a searchable database it can be used to identify gene families relevant to human disease.

NuTec is currently building a 5,000 CPU life sciences supercomputer in Atlanta that will have the capacity of 7.5 trillion calculations per second when the machine is completed this summer.  
The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.